KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Total Non-Current Liabilities (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Total Non-Current Liabilities for 15 consecutive years, with $390.7 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 17.57% to $390.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $390.7 million through Dec 2025, up 17.57% year-over-year, with the annual reading at $390.7 million for FY2025, 17.57% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $390.7 million at Supernus Pharmaceuticals, up from $358.6 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $871.0 million in Q1 2023, with the low at $309.1 million in Q1 2025.
  • Average Total Non-Current Liabilities over 5 years is $545.7 million, with a median of $377.6 million recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities rose 25.86% in 2021, then plummeted 62.97% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $837.7 million in 2021, then decreased by 3.59% to $807.6 million in 2022, then plummeted by 56.7% to $349.7 million in 2023, then fell by 4.97% to $332.3 million in 2024, then rose by 17.57% to $390.7 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $390.7 million, $358.6 million, and $310.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.